Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-02-25 @ 6:44 PM
Study NCT ID:
NCT01520558
Status:
UNKNOWN
Last Update Posted:
2017-06-29
First Post:
2012-01-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CNDO-109-AANK for AML in First Complete Remission (CR1)
Sponsor:
Coronado Biosciences, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia | View |